Medindia

X

Steerable Technologix LLC Announces Release of SurgiSteer Laparoscopic Instruments

Monday, June 28, 2010 General News J E 4
Advertisement


JACKSONVILLE, Fla., June 28 Steerable Technologix LLC announces the US release of its SurgiSteer(TM) laparoscopic instruments. Developed from licensed technology from OrthoDynamix LLC, the SurgiSteer product line will exploit single port laparoscopic surgery with its steerable 5mm instrumentation. The Lap Grasper, Maryland Dissector and Endo Scissors, available in both free and ratchet handle configurations are simplistic in use versus competitive devices. "Our design mission was to offer the most robust steerable laparoscopic instrument in the market while offering the surgeon a user friendly product with limited transitional barriers," said Bill Dennis, CEO. "Our devices exhibit many steerable features that heretofore haven't been available to the surgeon such as high force opening jaws for blunt tissue dissection, strong jaw closing force for reliably driving suture needles, and a very intuitive bend and locking mechanism which eliminates excessive hand motion. The SurgiSteer product portfolio will increase throughout the year to include RF devices," says Dennis.

Steerable instruments are necessary in one port surgery so as to create the proper orientation and/or triangulation for the surgeon while working through the umbilicus.

Steerable Technologix is a private equity funded medical device developer focused on disposable steerable instruments for general surgery, cardiovascular, spine, and ENT applications.

Steerable Technologix is a Gyrx LLC portfolio company.

SOURCE: Steerable Technologix LLC

CONTACT: Bill Dennis, CEO, bdennis@gyrx.com

SOURCE Steerable Technologix LLC
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Tolerx Presents Baseline Data from DEFEND-1 Study ...
S
New High-Resolution Computer Tomography Data Demon...